An important decision has been made about a controversial new drug to treat Alzheimer's disease.
The post Medicare and Medicaid place restrictions on new Alzheimer’s drug, Aduhelm (aducanumab) first appeared on Science-Based Medicine.from Science-Based Medicine https://sciencebasedmedicine.org/medicare-and-medicaid-place-restrictions-on-new-alzheimers-drug-aduhelm-aducanumab/?utm_source=rss&utm_medium=rss&utm_campaign=medicare-and-medicaid-place-restrictions-on-new-alzheimers-drug-aduhelm-aducanumab
No comments:
Post a Comment